New SterilizerTSO3 submits documentation to support export of new sterilizer to the United States and Europe
Stock symbol: TSX: TOS
Outstanding shares: 47,863,402
QUEBEC CITY, Dec. 29 /CNW Telbec/ -TSO3 Inc. ("TSO3") (TSX: TOS), an innovator in low temperaturesterilization technology for medical devices in healthcare settingsthrough the use of ozone, today announced that it has filed supportingtechnical documentation to the US Regulatory Agency and to the EuropeanNotified Body, in order to obtain clearance to export the STERIZONE(R)125L+ Sterilizer to these markets.
The Company announced receiving Health Canada authorization to market this sterilizer in Canada on December 17, 2009. In Canadathe new STERIZONE(R) 125L+ Sterilizer offers three cycles in a singlesterilizer and is able to meet healthcare sterilization demands forterminal sterilization that previously required two or more lowtemperature sterilization systems. Engineered like other TSO3 productsto be customer safe and eco-friendly, this new low temperaturesterilization system also offers increased speed and instrumentcompatibility, high throughput and cost effective sterilization.
"We are extremely pleased that we have met the milestones ofregulatory submission in multiple markets that we set out for ourselvesand communicated to our investors during the year", stated Mr. R.M.(Ric) Rumble, President and CEO of TSO3. "Our new total solution insterilization comes at a time when customers are seeking alternativesfor their low temperature sterilization needs", concludedMr. Rumble.
On December 16, 2009, TSO3 announced having enteredinto a global partnership with 3M, for the exclusive supply anddistribution of the STERIZONE(R) 125L+ Sterilizer through 3M'soperations worldwide as regulatory clearances are achieved.